Type 2 Diabetes is an Independent Negative Prognostic Factor in Patients Undergoing Surgical Resection of a WHO Grade I Meningioma
Intracranial meningiomas are the most frequently diagnosed primary brain tumors, accounting for roughly 1/3 of all diagnoses [1,2]. The majority of meningiomas carry a favorable prognosis, and amongst the operative cases the risk of postoperative morbidity and mortality is fairly low [3–5]. However, a number of factors have been associated with higher risk of perioperative complications and long-term mortality. Patient age, tumor size, pathological grade, tumor location, and extent of surgical resection are previously identified prognostic variables in patients undergoing a meningioma resection [6–12].
Source: Clinical Neurology and Neurosurgery - Category: Neurosurgery Authors: Arash Nayeri, Silky Chotai, Marc A. Prablek, Philip R Brinson, Diana G Douleh, Kyle D Weaver, Reid C Thompson, Lola Chambless Source Type: research
More News: Brain | Brain Cancers | Brain Tumor | Diabetes | Diabetes Type 2 | Endocrinology | Men | Neurology | Neurosurgery